Stochastic relationship between the growth fraction and vascularity of thin malignant melanomas.

[1]  I. Fidler.  Critical determinants of melanoma metastasis. , 1996, The journal of investigative dermatology. Symposium proceedings.

[2]  C. Miracco,et al.  Tumor vascularity as a prognostic indicator in intermediate-thickness (0.76-4 mm) cutaneous melanoma. A quantitative assay. , 1996, The American Journal of dermatopathology.

[3]  R. Walker.  EDITORIAL. ANGIOGENESIS AND BREAST CANCER PROGNOSIS—A CONTINUING ISSUE , 1996, The Journal of pathology.

[4]  A. Howell,et al.  TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN INFILTRATING LOBULAR CARCINOMA OF THE BREAST , 1996, The Journal of pathology.

[5]  R. Kerbel,et al.  Analysis and significance of the malignant 'eclipse' during the progression of primary cutaneous human melanomas. , 1996, The journal of investigative dermatology. Symposium proceedings.

[6]  A. Cochran,et al.  Tumor vascularity is not a prognostic factor for malignant melanoma of the skin. , 1995, The American journal of pathology.

[7]  A. Vortmeyer,et al.  Nucleolar Organizer Regions (AgNOR) and Ki‐67 Immunoreactivity in Cutaneous Melanocytic Lesions , 1995, The American Journal of dermatopathology.

[8]  D. Elder,et al.  Tumour vascularity is not a prognostic factor for cutaneous melanoma , 1994, The Lancet.

[9]  L. Ellis,et al.  The implications of angiogenesis for the biology and therapy of cancer metastasis , 1994, Cell.

[10]  R. Kerbel,et al.  Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas. , 1994, The American journal of pathology.

[11]  G. Piérard,et al.  Karyometry of Primary and Metastatic Malignant Melanoma: A Correlation with Cell Proliferation , 1994, The American Journal of dermatopathology.

[12]  S. Albelda,et al.  Expression of platelet‐endothelial cell adhesion molecule‐1 (PECAM‐1) during melanoma‐induced angiogenesis in vivo , 1993, Journal of cutaneous pathology.

[13]  D. Ribatti,et al.  Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67‐kilodalton laminin receptor , 1993, Cancer.

[14]  R. Barnhill,et al.  Regressing thin cutaneous malignant melanomas (< or = 1.0 mm) are associated with angiogenesis. , 1993, The American journal of pathology.

[15]  D. Ruiter,et al.  The possible role of angiogenesis in the metastatic potential of human melanoma. Clinicopathological aspects. , 1993, Melanoma research.

[16]  M C Mihm,et al.  Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. , 1992, Laboratory investigation; a journal of technical methods and pathology.

[17]  H. Soyer.  Kl 67 immunostaining in melanocytic skin tumors. Correlation with histologic parameters , 1991 .

[18]  G. Westbury,et al.  The vascularity of cutaneous melanoma: a quantitative histological study of lesions 0.85-1.25 mm in thickness. , 1991, British Journal of Cancer.

[19]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[20]  J. Folkman.  What is the evidence that tumors are angiogenesis dependent? , 1990, Journal of the National Cancer Institute.

[21]  R. Hofmann-Wellenhof,et al.  Vascular architecture of melanocytic skin tumors. A quantitative immunohistochemical study using automated image analysis. , 1989, Pathology, research and practice.

[22]  H. Soyer,et al.  Proliferative Activity of Cutaneous Melanocytic Tumors Defined by Ki‐67 Monoclonal Antibody: A Quantitative Immunohistochemical Study , 1989, The American Journal of dermatopathology.

[23]  D. Hanahan,et al.  Induction of angiogenesis during the transition from hyperplasia to neoplasia , 1989, Nature.

[24]  W. Stolz,et al.  Tumor cell growth fractions in human malignant melanomas and the correlation to histopathologic tumor grading. , 1989, The American journal of pathology.

[25]  A. Srivastava,et al.  The prognostic significance of tumor vascularity in intermediate-thickness (0.76-4.0 mm thick) skin melanoma. A quantitative histologic study. , 1988, The American journal of pathology.

[26]  J. Folkman.  What is the role of angiogenesis in metastasis from cutaneous melanoma? , 1987, European journal of cancer & clinical oncology.

[27]  A. Srivastava,et al.  Neovascularization in human cutaneous melanoma: a quantitative morphological and Doppler ultrasound study. , 1986, European journal of cancer & clinical oncology.

[28]  M. Fishbein,et al.  Endothelial cell markers in vascular neoplasms: An immunohistochemical study comparing factor VIII‐related antigen, blood group specific antigens, 6‐keto‐PGF1 alpha, and Ulex europaeus 1 lectin , 1986, The Journal of pathology.

[29]  Ordóñez Ng,et al.  Comparison of Ulex europaeus I lectin and factor VIII-related antigen in vascular lesions. , 1984 .

[30]  Claudio Eccher,et al.  Microvessel density quantification in breast carcinomas. Assessment by light microscopy vs. a computer-aided image analysis system , 1995 .

[31]  G. Piérard,et al.  The proliferative activity of cells of malignant melanomas. , 1984, The American Journal of dermatopathology.